Annual Review 2006 This Information is Intended for Investors CoverChairman's Letter to ShareholdersFinancial HighlightsOur Prescription for Change: Action PlanMaximizing Revenues in the Short and Long Term Key Human Health Medicines Resurgence in R&D Business DevelopmentEstablishing a Lower, More Flexible Cost BaseCreating Smaller, More Accountable Operating UnitsEngaging Collaboratively with Parents, Customers and...Making Pfizer a Great Place to WorkBoard of DirectorsCorporate and Shareholder InformationBack Cover Page 1 of Advisory Information for Investors Page 1 of Download Full PDF
